126 related articles for article (PubMed ID: 32197875)
1. Large-sized squamous carcinoma of the conjunctiva. Role of coadjuvant treatment with interferon α-2b.
Gargallo-Benedicto A; Clemente-Tomás R; Pastor Espuig M; Navarro Casado MN
Arch Soc Esp Oftalmol (Engl Ed); 2020 Jul; 95(7):e52. PubMed ID: 32197875
[No Abstract] [Full Text] [Related]
2. Conjunctival papillomatosis in children treated with co-adjuvant topical interferon alpha-2b.
Rodríguez-Cabrera L; García-Regil P; Velasco-Levy A; Serna-Ojeda JC
Arch Soc Esp Oftalmol (Engl Ed); 2019 Jul; 94(7):352-354. PubMed ID: 30424910
[TBL] [Abstract][Full Text] [Related]
3. Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study.
Blasi MA; Maceroni M; Sammarco MG; Pagliara MM
Eur J Ophthalmol; 2018 Mar; 28(2):204-209. PubMed ID: 28967069
[TBL] [Abstract][Full Text] [Related]
4. Treatment of conjunctival squamous neoplasias with interferon alpha 2ab.
Huerva V; Mangues I
J Fr Ophtalmol; 2008 Mar; 31(3):317-25. PubMed ID: 18404128
[TBL] [Abstract][Full Text] [Related]
5. Conjunctival Lesion in a Patient With Ocular Graft-vs-Host Disease.
Paley GL; Farooq AV; Lubniewski AJ
JAMA Ophthalmol; 2017 Aug; 135(8):883-884. PubMed ID: 28494062
[No Abstract] [Full Text] [Related]
6. Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia.
Venkateswaran N; Mercado C; Galor A; Karp CL
Am J Ophthalmol; 2019 Mar; 199():216-222. PubMed ID: 30471241
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control].
Cartsburg O; Kersten A; Sundmacher R; Nadjari B; Pomjanski N; Böcking A
Klin Monbl Augenheilkd; 2001 Jun; 218(6):429-34. PubMed ID: 11488009
[TBL] [Abstract][Full Text] [Related]
8. Surgery Versus Interferon Alpha-2b Treatment Strategies for Ocular Surface Squamous Neoplasia: A Literature-Based Decision Analysis.
Siedlecki AN; Tapp S; Tosteson AN; Larson RJ; Karp CL; Lietman T; Zegans ME
Cornea; 2016 May; 35(5):613-8. PubMed ID: 26890663
[TBL] [Abstract][Full Text] [Related]
9. Ocular surface squamous neoplasia treated with topical interferon α 2b.
Pujari A
BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28100578
[No Abstract] [Full Text] [Related]
10. Interferon alpha-2a as alternative treatment for conjunctival squamous cell carcinoma.
Cruzado-Sánchez D; Salas-Diaz M; Tellez WA; Alvarez-Matos SE; Serpa-Frías S
Arch Soc Esp Oftalmol; 2017 Nov; 92(11):539-542. PubMed ID: 28522115
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of Topical Interferon Alpha-2b Eye Drop as an Adjunctive Therapy Following Surgical Resection in Ocular Surface Squamous Neoplasia.
Kanaya R; Kase S; Ishijima K; Ishida S
In Vivo; 2019; 33(6):2211-2215. PubMed ID: 31662558
[TBL] [Abstract][Full Text] [Related]
12. Study of efficacy and safety of reconstituted, recombinant human interferon alpha 2b eyedrops without refrigeration as a therapy for immunoreduction and/or treatment of ocular surface squamous neoplasia.
Kabra NS; Patil VS; Dhanuka DG
Indian J Ophthalmol; 2021 Dec; 69(12):3776-3777. PubMed ID: 34827049
[No Abstract] [Full Text] [Related]
13. Successful Treatment of Exuberant Conjunctival Squamous Papilloma.
Eldeeb M; Hegazy O; Chan EW
JAMA Ophthalmol; 2020 Feb; 138(2):e190930. PubMed ID: 32053177
[No Abstract] [Full Text] [Related]
14. Giant conjunctival squamous cell carcinoma. Treatment with surgery following topical interferon alpha-2b.
Murcia Bello C; Lleó Pérez AV; Navarro Piera JF
Arch Soc Esp Oftalmol; 2016 Apr; 91(4):188-90. PubMed ID: 26827157
[TBL] [Abstract][Full Text] [Related]
15. Conjunctival papilloma: features and outcomes based on age at initial examination.
Kaliki S; Arepalli S; Shields CL; Klein K; Sun H; Hysenj E; Lally SE; Shields JA
JAMA Ophthalmol; 2013 May; 131(5):585-93. PubMed ID: 23538642
[TBL] [Abstract][Full Text] [Related]
16. Relapsed ocular squamous surface neoplasia treated with topical interferon alfa-2b.
Rocha-de-Lossada C; Alba-Linero C; Borroni D; Rachwani-Anil R; Zamorano-Martín F; Rodríguez-Calvo-de-Mora M
Rom J Ophthalmol; 2020; 64(1):62-65. PubMed ID: 32292860
[TBL] [Abstract][Full Text] [Related]
17. Immunoreduction of locally advanced orbito-conjunctival squamous cell carcinoma with intraorbital interferon alpha-2b injection: a globe saving approach.
Meel R; Dhiman R; Sen S; Sharma S
Clin Exp Ophthalmol; 2018 Jan; 46(1):87-88. PubMed ID: 28570760
[No Abstract] [Full Text] [Related]
18. Interferon alpha-2b in giant ocular surface squamous neoplasia.
Hernandez-Bogantes E; Serna-Ojeda JC; Lichtinger A; Graue-Hernández EO
Indian J Ophthalmol; 2016 May; 64(5):393-4. PubMed ID: 27380981
[No Abstract] [Full Text] [Related]
19. Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up.
Zaki AA; Farid SF
Cornea; 2009 Oct; 28(9):986-8. PubMed ID: 19724215
[TBL] [Abstract][Full Text] [Related]
20. [Conjunctival squamous cell carcinoma requiring orbital exenteration: case report].
Satto LH; Marques ME; Schellini SA
Arq Bras Oftalmol; 2012; 75(1):61-3. PubMed ID: 22552421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
